The potential of targeting NMDA receptors outside the CNS

Bibliography

• Haddad JJ. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol 2005;77:252-82
   PubMed Web of Science ®Google Scholar
• Wang Y, Durkin JP. alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, but not N-methyl-D-aspartate, activates mitogen-activated protein kinase through G-protein beta gamma subunits in rat cortical neurons. J Biol Chem 1995;270:22783-7
   PubMed Web of Science ®Google Scholar
• Ahn YM, Oh SW, Kang UG, et al. An N-methyl-D-aspartate antagonist, MK-801, preferentially reduces electroconvulsive shock-induced phosphorylation of p38 mitogen-activated protein kinase in the rat hippocampus. Neurosci Lett 2000;296:101-4
   PubMed Web of Science ®Google Scholar
• Cammarota M, Bevilaqua LR, Ardenghi P, et al. Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade. Brain Res Mol Brain Res 2000;76:36-46
   PubMedGoogle Scholar
• Chandler LJ, Sutton G, Dorairaj NR, et al. N-methyl D-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J Biol Chem 2001;276:2627-36
   PubMed Web of Science ®Google Scholar
• Jiang Q, Gu Z, Zhang G, et al. N-methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apototic-like death. Brain Res 2000;887:285-92
   PubMed Web of Science ®Google Scholar
• Zeng L, Lu L, Muller M, et al. Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors. J Mol Neurosci 2002;19:113-16
   PubMed Web of Science ®Google Scholar
• Barnstable CJ, Wei JY, Han MH. Modulation of synaptic function by cGMP and cGMP-gated cation channels. Neurochem Int 2004;45:875-84
   PubMed Web of Science ®Google Scholar
• Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365-402
   PubMed Web of Science ®Google Scholar
• Hollmann M, O’Shea-Greenfield A, Rogers SW, et al. Cloning by functional expression of a member of the glutamate receptor family. Nature 1989;342:643-8
   PubMed Web of Science ®Google Scholar
• Gladding CM, Fitzjohn SM, Molnar E. Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms. Pharmacol Rev 2009;61:395-412
   PubMed Web of Science ®Google Scholar
• Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61
   PubMed Web of Science ®Google Scholar
• Cull-Candy SG, Brickley SG, Misra C, et al. NMDA receptor diversity in the cerebellum: identification of subunits contributing to functional receptors. Neuropharmacology 1998;37:1369-80
   PubMed Web of Science ®Google Scholar
• Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001;11:327-35
   PubMed Web of Science ®Google Scholar
• Forrest D, Yuzaki M, Soares HD, et al. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 1994;13:325-38
   PubMed Web of Science ®Google Scholar
• Scheetz AJ, Constantine-Paton M. Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J 1994;8:745-52
   PubMed Web of Science ®Google Scholar
• Hardingham GE, Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci 2003;26:81-9
   PubMed Web of Science ®Google Scholar
• Guttmann RP, Sokol S, Baker DL, et al. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther 2002;302:1023-30
   PubMed Web of Science ®Google Scholar
• Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans 2009;37:1147-60
   PubMed Web of Science ®Google Scholar
• Loftis JM, Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 2003;97:55-85
   PubMed Web of Science ®Google Scholar
• Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-22
   PubMed Web of Science ®Google Scholar
• Miglio G, Dianzani C, Fallarini S, et al. Stimulation of N-methyl-D-aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. Biochem Biophys Res Commun 2007;361:404-9
   PubMed Web of Science ®Google Scholar
• Nahm WK, Philpot BD, Adams MM, et al. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol 2004;200:309-17
   PubMed Web of Science ®Google Scholar
• Mentaverri R, Kamel S, Wattel A, et al. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor. J Cell Biochem 2003;88:1145-56
   PubMed Web of Science ®Google Scholar
• Rakic P, Komuro H. The role of receptor/channel activity in neuronal cell migration. J Neurobiol 1995;26:299-315
   PubMedGoogle Scholar
• Shorte SL. N-methyl-D-aspartate evokes rapid net depolymerization of filamentous actin in cultured rat cerebellar granule cells. J Neurophysiol 1997;78:1135-43
   PubMed Web of Science ®Google Scholar
• Itzstein C, Espinosa L, Delmas PD, et al. Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption. Biochem Biophys Res Commun 2000;268:201-9
   PubMed Web of Science ®Google Scholar
• Parisi E, Almaden Y, Ibarz M, et al. N-methyl-D-aspartate receptors are expressed in rat parathyroid gland and regulate PTH secretion. Am J Physiol Renal Physiol 2009;296:F1291-6
   PubMed Web of Science ®Google Scholar
• Magnusson KR. The aging of the NMDA receptor complex. Front Biosci 1998;3:e70-80
   PubMedGoogle Scholar
• Bellone C, Nicoll RA. Rapid bidirectional switching of synaptic NMDA receptors. Neuron 2007;55:779-85
   PubMed Web of Science ®Google Scholar
• Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 2007;7:39-47
   PubMed Web of Science ®Google Scholar
• Rebola N, Srikumar BN, Mulle C. Activity-dependent synaptic plasticity of NMDA receptors. J Physiol 2010;588:93-9
   PubMed Web of Science ®Google Scholar
• Luo J, Wang Y, Yasuda RP, et al. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 1997;51:79-86
   PubMed Web of Science ®Google Scholar
• Chazot PL. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr Med Chem 2004;11:389-96
   PubMed Web of Science ®Google Scholar
• Ishii T, Moriyoshi K, Sugihara H, et al. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 1993;268:2836-43
   PubMed Web of Science ®Google Scholar
• Meguro H, Mori H, Araki K, et al. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 1992;357:70-4
   PubMed Web of Science ®Google Scholar
• Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992;258:597-603
   PubMed Web of Science ®Google Scholar
• Ciabarra AM, Sullivan JM, Gahn LG, et al. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 1995;15:6498-508
   PubMed Web of Science ®Google Scholar
• Lynch DR, Guttmann RP. NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets 2001;2:215-31
   PubMed Web of Science ®Google Scholar
• Das S, Sasaki YF, Rothe T, et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998;393:377-81
   PubMed Web of Science ®Google Scholar
• Nishi M, Hinds H, Lu HP, et al. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 2001;21:RC185
   PubMed Web of Science ®Google Scholar
• Matsuda K, Fletcher M, Kamiya Y, et al. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci 2003;23:10064-73
   PubMed Web of Science ®Google Scholar
• Perez-Otano I, Ehlers MD. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 2004;13:175-89
   PubMedGoogle Scholar
• Al-Hallaq R, Jarabek B, Fu Z, et al. Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol 2002;62:1119-27
   PubMed Web of Science ®Google Scholar
• Ulbrich M, Isacoff E. Rules of engagement for NMDA receptor subunits. Proc Natl Acad Sci USA 2008;105:14163-8
   PubMed Web of Science ®Google Scholar
• Chatterton J, Awobuluyi M, Premkumar L, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002;415:793-8
   PubMed Web of Science ®Google Scholar
• Cavara N, Orth A, Hollmann M. Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors. BMC Neurisci 2009;10:1-11
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Morita K, Kinjo K, et al. Stimulation of catecholamine release from isolated adrenal glands by some amino acids. Jpn J Pharmacol 1982;32:291-7
   PubMedGoogle Scholar
• Moroni F, Luzzi S, Franchi-Micheli S, et al. The presence of N-methyl-D-aspartate-type receptors for glutamic acid in the guinea pig myenteric plexus. Neurosci Lett 1986;68:57-62
   PubMed Web of Science ®Google Scholar
• Morhenn VB, Waleh NS, Mansbridge JN, et al. Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes. Eur J Pharmacol 1994;268:409-14
   PubMed Web of Science ®Google Scholar
• Chen HJ, Fitzgerald R, Brown AT, et al. Identification of a homocysteine receptor in the peripheral endothelium and its role in proliferation. J Vasc Surg 2005;41:853-60
   PubMed Web of Science ®Google Scholar
• Mcgee MA, Abdel-Rahman AA. Enhanced vascular neuronal nitric-oxide synthase-derived nitric-oxide production underlies the pressor response caused by peripheral N-methyl-D-aspartate receptor activation in conscious rats. J Pharmacol Exp Ther 2012;342:461-71
   PubMed Web of Science ®Google Scholar
• Leung JC, Travis BR, Verlander JW, et al. Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system. Am J Physiol Regul Integr Comp Physiol 2002;283:R964-71
   PubMed Web of Science ®Google Scholar
• Patton AJ, Genever PG, Birch MA, et al. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 1998;22:645-9
   PubMed Web of Science ®Google Scholar
• Seeber S, Becker K, Rau T, et al. Transient expression of NMDA receptor subunit NR2B in the developing rat heart. J Neurochem 2000;75:2472-7
   PubMed Web of Science ®Google Scholar
• Deng A, Valdivielso JM, Munger KA, et al. Vasodilatory N-methyl-D-aspartate receptors are constitutively expressed in rat kidney. J Am Soc Nephrol 2002;13:1381-4
   PubMed Web of Science ®Google Scholar
• Gill SS, Pulido OM, Mueller RW, et al. Molecular and immunochemical characterization of the ionotropic glutamate receptors in the rat heart. Brain Res Bull 1998;46:429-34
   PubMed Web of Science ®Google Scholar
• Gill S, Pulido OM. Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol Pathol 2001;29:208-23
   PubMed Web of Science ®Google Scholar
• Lin YJ, Bovetto S, Carver JM, et al. Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery. Brain Res Mol Brain Res 1996;43:57-64
   PubMedGoogle Scholar
• Gonzalez-Cadavid NF, Ryndin I, Vernet D, et al. Presence of NMDA receptor subunits in the male lower urogenital tract. J Androl 2000;21:566-78
   PubMed Web of Science ®Google Scholar
• Ma MC, Huang HS, Chen YS, et al. Mechanosensitive N-methyl-D-aspartate receptors contribute to sensory activation in the rat renal pelvis. Hypertension 2008;52:938-U545
   PubMed Web of Science ®Google Scholar
• Parisi E, Bozic M, Ibarz M, et al. Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT. Am J Physiol Endocrinol Metab 2010;299:E825-31
   PubMed Web of Science ®Google Scholar
• Bozic M, de Rooij J, Parisi E, et al. Glutamatergic Signaling Maintains the Epithelial Phenotype of Proximal Tubular Cells. J Am Soc Nephrol 2011;22:1099-111
   PubMed Web of Science ®Google Scholar
• Nasstrom J, Boo E, Stahlberg M, et al. Tissue distribution of two NMDA receptor antagonists, [3H]CGS 19755 and [3H]MK-801, after intrathecal injection in mice. Pharmacol Biochem Behav 1993;44:9-15
   PubMed Web of Science ®Google Scholar
• Deng A, Thomson SC. Renal NMDA receptors independently stimulate proximal reabsorption and glomerular filtration. Am J Physiol Renal Physiol 2009;296:F976-82
   PubMed Web of Science ®Google Scholar
• Zhang C, Yi F, Xia M, et al. NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats. Antioxid Redox Signal 2010;13:975-86
   PubMed Web of Science ®Google Scholar
• Anderson M, Suh JM, Kim EY, et al. Functional NMDA receptors with atypical properties are expressed in podocytes. Am J Physiol Cell Physiol 2011;300:C22-32
   PubMed Web of Science ®Google Scholar
• Giardino L, Armelloni S, Corbelli A, et al. Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 2009;20:1929-40
   PubMed Web of Science ®Google Scholar
• Sproul AD, Steele SL, Thai TL, et al. N-methyl-D-aspartate receptor subunit NR3a expression and function in principal cells of the collecting duct. Am J Physiol Renal Physiol 2011;301:F44-54
   PubMed Web of Science ®Google Scholar
• Gu Y, Genever PG, Skerry TM, et al. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif Tissue Int 2002;70:194-203
   PubMed Web of Science ®Google Scholar
• Itzstein C, Cheynel H, Burt-Pichat B, et al. Molecular identification of NMDA glutamate receptors expressed in bone cells. J Cell Biochem 2001;82:134-44
   PubMed Web of Science ®Google Scholar
• Ho ML, Tsai TN, Chang JK, et al. Down-regulation of N-methyl D-aspartate receptor in rat-modeled disuse osteopenia. Osteoporos Int 2005;16:1780-8
   PubMed Web of Science ®Google Scholar
• Chenu C, Serre CM, Raynal C, et al. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 1998;22:295-9
   PubMed Web of Science ®Google Scholar
• Kalariti N, Lembessis P, Koutsilieris M. Characterization of the glutamatergic system in MG-63 ostoblast-like osteosarcoma cells. Anticancer Res 2004;24:3923-30
   PubMedGoogle Scholar
• Merle B, Itzstein C, Delmas PD, et al. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. J Cell Biochem 2003;90:424-36
   PubMed Web of Science ®Google Scholar
• Hinoi E, Fujimori S, Takarada T, et al. Facilitation of glutamate release by ionotropic glutamate receptors in osteobasts. Biochem Biophys Res Commun 2002;297:452-8
   PubMed Web of Science ®Google Scholar
• Gu YC, Publicover SJ. Expression of functional metabotropic glutamate receptors primary cultured rat osteoblasts - Cross-talk with N-methyl-D-aspartate receptors. J Biol Chem 2000;275:34252-9
   PubMed Web of Science ®Google Scholar
• Fujita H, Hinoi E, Nakatani E, et al. Possible modulation of process extension by N-methyl-D-aspartate receptor expressed in osteocytic MLO-Y4 cells. J Pharmacol Sci 2012;119:112-16
   PubMed Web of Science ®Google Scholar
• Corsi M, Fina P, Trist DG. Co-agonism in drug-receptor interaction: illustrated by the NMDA receptors. Trends Pharmacol Sci 1996;17:220-2
   PubMed Web of Science ®Google Scholar
• Hood WF, Sun ET, Compton RP, Monahan JB. 1-Aminocyclobutane-1-carboxylate (ACBC): a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor. Eur J Pharmacol 1989;161:281-2
   PubMed Web of Science ®Google Scholar
• Lynch DR, Guttmann RP. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther 2002;300:717-23
   PubMed Web of Science ®Google Scholar
• Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-31
   PubMed Web of Science ®Google Scholar
• Kupper J, Ascher P, Neyton J. Internal Mg2+ block of recombinant NMDA channels mutated within the selectivity filter and expressed in Xenopus oocytes. J Physiol 1998;507(Pt 1):1-12
   PubMed Web of Science ®Google Scholar
• Kuner T, Schoepfer R. Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. J Neurosci 1996;16:3549-58
   PubMed Web of Science ®Google Scholar
• Vissel B, Krupp JJ, Heinemann SF, et al. Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-D-aspartate receptors. Mol Pharmacol 2002;61:595-605
   PubMed Web of Science ®Google Scholar
• Traynelis SF, Burgess MF, Zheng F, et al. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 1998;18:6163-75
   PubMed Web of Science ®Google Scholar
• Duguid IC, Smart TG. Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses. Nat Neurosci 2004;7:525-33
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Tanaka I, Tamura M, et al. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 2004;309:884-93
   PubMed Web of Science ®Google Scholar
• Paoletti P, Vergnano AM, Barbour B, et al. Zinc at glutamatergic synapses. Neuroscience 2009;158:126-36
   PubMed Web of Science ®Google Scholar
• Omelchenko IA, Nelson CS, Allen CN. Lead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits. J Pharmacol Exp Ther 1997;282:1458-64
   PubMed Web of Science ®Google Scholar
• Guilarte TR, McGlothan JL. Selective decrease in NR1 subunit splice variant mRNA in the hippocampus of Pb2+-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes. Brain Res Mol Brain Res 2003;113:37-43
   PubMedGoogle Scholar
• Nagy J. The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence. Curr Drug Targets CNS Neurol Disord 2004;3:169-79
   PubMedGoogle Scholar
• Mony L, Kew JN, Gunthorpe MJ, et al. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 2009;157:1301-17
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Weller M, Schoppmeyer K, et al. Amantadine and memantine are nmda receptor antagonists with neuroprotective properties. J Neural Transm Suppl 1994;43:91-104
   PubMedGoogle Scholar
• Huettner JE, Bean BP. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 1988;85:1307-11
   PubMed Web of Science ®Google Scholar
• Fagg GE. Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes. Neurosci Lett 1987;76:221-7
   PubMed Web of Science ®Google Scholar
• Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 1993;44:851-9
   PubMed Web of Science ®Google Scholar
• Perin-Dureau F, Rachline J, Neyton J, et al. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 2002;22:5955-65
   PubMed Web of Science ®Google Scholar
• Malherbe P, Mutel V, Broger C, et al. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. J Pharmacol Exp Ther 2003;307:897-905
   PubMed Web of Science ®Google Scholar
• Ganor Y, Levite M. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm 2014;121:983-1006
   PubMed Web of Science ®Google Scholar
• Divino Filho J, Hazel S, Fürst P, et al. Glutamate concentration in plasma, erythrocyte and muscle in relation to plasma levels of insulin-like growth factor (IGF)-I, IGF binding protein-1 and insulin in patients on haemodialysis. J Endocrinol 1998;156:519-27
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou L, Xu HF, et al. A preliminary experimental study on the cardiac toxicity of glutamate and the role of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor in rats. Chin Med J (Engl) 2013;126:1323-32
   PubMed Web of Science ®Google Scholar
• Lin TH, Yang RS, Tang CH, et al. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur J Pharmacol 2008;589:37-44
   PubMed Web of Science ®Google Scholar
• Mason D, Suva LJ, Genever P, et al. Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 1997;20:199-205
   PubMed Web of Science ®Google Scholar
• Hinoi E, Yoneda Y. Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis. J Pharmacol Sci 2011;116:248-56
   PubMed Web of Science ®Google Scholar
• Ralphe J, Segar J, Schutte B, et al. Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J Mol Cell Cardiol 2004;37:33-41
   PubMed Web of Science ®Google Scholar
• Hediger M. Glutamate transporters in kidney and brain. Am J Physiol 1999;277:F487-92
   PubMedGoogle Scholar
• Welbourne T, Matthews J. Glutamate transporters and renal function. Am J Physiol 1999;277:F501-5
   PubMedGoogle Scholar
• Laketic-Ljubojevic I, Suva LJ, Maathuis F, et al. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 1999;25:631-7
   PubMed Web of Science ®Google Scholar
• Xue H, Field C. New role of glutamate as an immunoregulator via glutamate receptors and transporters. Front Biosci (Schol Ed) 2011;1:1007-20
   Google Scholar
• Slomowitz LA, Gabbai FB, Khang SJ, et al. Protein intake regulates the vasodilatory function of the kidney and NMDA receptor expression. Am J Physiol Regul Integr Comp Physiol 2004;287:R1184-9
   PubMed Web of Science ®Google Scholar
• Kim EY, Anderson M, Dryer SE. Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death. Mol Pharmacol 2012;82:728-37
   PubMed Web of Science ®Google Scholar
• Franke WW, Schmid E, Osborn M, et al. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci USA 1978;75:5034-8
   PubMed Web of Science ®Google Scholar
• Frokiaer J. Collecting duct expression of N-methyl-D-aspartate receptor subtype NR3a regulates urinary concentrating capacity. Am J Physiol Renal Physiol 2011;301:F42-3
   PubMed Web of Science ®Google Scholar
• Leung JC, Marphis T, Craver RD, et al. Altered NMDA receptor expression in renal toxicity: protection with a receptor antagonist. Kidney Int 2004;66:167-76
   PubMed Web of Science ®Google Scholar
• Leung JC, Ragland N, Marphis T, et al. NMDA Agonists and Antagonists Induce Renal Culture Cell Toxicity. Med Chem 2008;4:565-71
   PubMed Web of Science ®Google Scholar
• Basile AS, Huang JM, Xie C, et al. N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med 1996;2:1338-43
   PubMed Web of Science ®Google Scholar
• Puel JL, Ladrech S, Chabert R, et al. Electrophysiological Evidence for the Presence of Nmda Receptors in the Guinea-Pig Cochlea. Hear Res 1991;51:255-64
   PubMed Web of Science ®Google Scholar
• Segal JA, Harris BD, Kustova Y, et al. Aminoglycoside neurotoxicity involves NMDA receptor activation. Brain Res 1999;815:270-7
   PubMed Web of Science ®Google Scholar
• Arora S, Kaur T, Kaur A, et al. Glycine aggravates ischemia reperfusion-induced acute kidney injury through N-Methyl-D-Aspartate receptor activation in rats. Mol Cell Biochem 2014;393:123-31
   PubMed Web of Science ®Google Scholar
• Yang CC, Chien CT, Wu MH, et al. NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys. Am J Physiol Renal Physiol 2008;294:F1433-40
   PubMed Web of Science ®Google Scholar
• Pundir M, Arora S, Kaur T, et al. Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury. J Surg Res 2013;183:668-77
   PubMed Web of Science ®Google Scholar
• Peet NM, Grabowski PS, Laketic-Ljubojevic I, et al. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J 1999;13:2179-85
   PubMed Web of Science ®Google Scholar
• Gray C, Marie H, Arora M, et al. Glutamate does not play a major role in controlling bone growth. J Bone Miner Res 2001;16:742-9
   PubMed Web of Science ®Google Scholar
• Hinoi E, Fujimori S, Yoneda Y. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J 2003;17:1532-4
   PubMed Web of Science ®Google Scholar
• Li JL, Zhao L, Cui B, et al. Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro. Acta Pharmacol Sin 2011;32:895-903
   PubMed Web of Science ®Google Scholar
• Li JL, Cui B, Qi L, et al. NMDA enhances stretching-induced differentiation of osteobalsts through the ERK1/2 signaling pathway. Bone 2008;43:469-75
   PubMed Web of Science ®Google Scholar
• Szczesniak AM, Gilbert RW, Mukhida M, et al. Mechanical loading modulates glutamate receptor subunit expression in bone. Bone 2005;37:63-73
   PubMed Web of Science ®Google Scholar
• Koizumi M, Komaba H, Fukagawa M. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Contrib Nephrol 2013;180:110-23
   PubMed Web of Science ®Google Scholar
• D’Amico M, Di Filippo C, Rossi F, et al. Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. Eur J Pharmacol 1999;366:167-74
   PubMed Web of Science ®Google Scholar
• Shi S, Liu T, Li Y, et al. Chronic N-Methyl-D-aspartate receptor activation induces cardiac electrical remodeling and increases susceptibility to ventricular arrhythmias. Pacing Clin Electrophysiol 2014;37(10):1367-77
   PubMed Web of Science ®Google Scholar
• Maldonado C, Soni CV, Todnem ND, et al. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curr Vasc Pharmacol 2010;8:64-74
   PubMed Web of Science ®Google Scholar
• Sun XL, Zhong JQ, Wang DG, et al. Increasing glutamate promotes ischemia-reperfusion-induced ventricular arrhythmias in rats in vivo. Pharmacology 2014;93:4-9
   PubMed Web of Science ®Google Scholar
• Huang CF, Su MJ. Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci 1999;6:387-98
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Miller JP, Bigger JT, et al. Decreased heart-rate-variability and its association with increased mortality after acute myocardial-infarction. Am J Cardiol 1987;59:256-62
   PubMed Web of Science ®Google Scholar
• Bennett AJ, DePetrillo PB. Differential effects of MK801 and lorazepam on heart rate variability in adolescent rhesus monkeys (Macoca mulatta). J Cardiovasc Pharmacol 2005;45:383-8
   PubMed Web of Science ®Google Scholar
• Aya AGM, Robert E, Bruelle P, et al. Effects of ketamine on ventricular conduction, refractoriness, and wavelength - Potential antiarrhythmic effects: a high-resolution epicardial mapping in rabbit hearts. Anesthesiology 1997;87:1417-27
   PubMed Web of Science ®Google Scholar
• Baczko I, Lepran I, Papp JG. Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats. J Cardiovasc Pharmacol 1997;29:196-201
   PubMed Web of Science ®Google Scholar
• Hageman GR, Simor T. Attenuation of the cardiac effects of cocaine by dizocilpine. Am J Physiol 1993;264:H1890-5
   PubMedGoogle Scholar
• Gao X, Xu X, Pang J, et al. NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol Res 2007;56:559-69
   PubMed Web of Science ®Google Scholar
• Tyagi N, Vacek JC, Givvimani S, et al. Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J Recept Signal Transduct Res 2010;30:78-87
   PubMed Web of Science ®Google Scholar
• Moshal KS, Tipparaju SM, Vacek TP, et al. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 2008;295:H890-7
   PubMed Web of Science ®Google Scholar
• Tyagi N, Mishra PK, Tyagi SC. Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure. Indian J Biochem Biophys 2009;46:441-6
   PubMed Web of Science ®Google Scholar
• Meng L, Zhang ZX, Xu K, et al. HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptor. Int J Cardiol 2013;167:2517-23
   PubMed Web of Science ®Google Scholar
• Meneghini A, Ferreira C, de Abreu LC, et al. Memantine prevents cardiomyocytes nuclear size reduction in the left ventricle of rats exposed to cold stress. Clinics 2009;64:921-6
   PubMed Web of Science ®Google Scholar
• Watanabe M, Mishina M, Inoue Y. Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland. Neurosci Lett 1994;165:183-6
   PubMed Web of Science ®Google Scholar